Ira Zackon, MD, discussed his retrospective study which aimed to understand patient characteristics, treatment patterns, and OS of patients with higher-risk MDS treated in the community oncology setting.
Belong.Life is a global leader in digital health, revolutionizing the patient experience and delivering unparalleled value for patients, healthcare providers, pharmaceutical companies, and payers.
Belong’s key solutions include the world’s largest social and professional networks for people living with cancer (Belong – Beating Cancer Together) and multiple sclerosis (BelongMS), and the BelongAI health-grade patient engagement and support platforms including Dave AI Cancer Mentor medically validated by renowned oncologists at ASCO and ESMO, Sophie– AI MS Mentor, Tara – AI Clinical Trials Matching Assistant and Fred – AI Weight and Health Mentor, which utilizes AI to proactively support and empower patients throughout their healthcare journey.
